This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Polysaccharide A (Symbiotix)
Symbiotix Biotherapies, Inc.
Drug Names(s): Polysaccharide A, PSA
Description: Polysaccharide A (PSA) is a first-in-class oral therapy that works through a novel mechanism of action related to activation of regulatory T cells, which exert an anti-inflammatory effect through the production of IL-10.
Polysaccharide A (Symbiotix) News
Additional information available to subscribers only: